Cargando…
Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy
Cancer immunotherapy, especially immune checkpoint therapy, has revolutionized therapeutic options by reactivating the host immune system. However, the efficacy varies, and only a small portion of patients develop sustained antitumor responses. Hence, illustrating novel strategies that improve the c...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942356/ https://www.ncbi.nlm.nih.gov/pubmed/36810108 http://dx.doi.org/10.1186/s12943-023-01746-6 |